Myasthenia gravis and preeclampsia

Area of Science:

• Neurology
• Obstetrics
• Pharmacology

Background:

• Myasthenia gravis (MG) is a rare autoimmune disorder affecting neuromuscular junctions.
• Pregnancy in women with MG presents unique clinical challenges.
• The co-occurrence of MG and preeclampsia has not been previously documented.

Observation:

• This report details a case of preeclampsia in a patient with myasthenia gravis.
• Management strategies for this specific patient were carefully considered.

Findings:

• Magnesium administration is identified as a contraindicated pharmacologic agent in myasthenic patients.
• This finding is crucial for managing pregnant patients with MG and superimposed preeclampsia.

Implications:

• Clinical guidelines for managing myasthenia gravis in pregnancy require updates.
• Healthcare providers should exercise caution when considering magnesium for preeclampsia in MG patients.
• Further research is needed to explore safe and effective treatment protocols.